Stocks Health care FEED
NASDAQ · Health careENvue Medical, Inc. (FEED)
ENvue Medical, Inc. brought in $1.9M of revenue over the twelve months to June 30, 2026, down 17.7% from a year earlier. It posted a net loss of $21.1M. In fiscal 2025 capital spending exceeded operating cash flow by $9.4M. At June 30, 2026 it held $1.1M in cash. Its latest periodic report to the SEC is the quarterly report (10-Q) filed on August 17, 2026.
What ENvue Medical, Inc. does
ENvue Medical, Inc. is registered with the SEC under industry code SIC 3842 (Orthopedic, Prosthetic & Surgical Appliances & Supplies). Its shares trade on NASDAQ under the ticker FEED.
Revenue and profit by year
Key figures
| Fiscal year | Revenue | Net income | Diluted EPS | Free cash flow |
|---|---|---|---|---|
| 2025 | $2.6M | -$18.2M | -$26.69 | -$9.4M |
| 2024 | $2.6M | -$3.7M | -$137.30 | -$2.5M |
| 2023 | $2.3M | -$3.7M | -$233.20 | -$3.6M |
| 2022 | $752K | -$5.4M | -$422.40 | -$7M |
| 2021 | $1.7M | -$14.3M | -$62.70 | -$4.4M |
| 2020 | $623K | -$4.3M | -$46.20 | -$3.4M |
Where FEED ranks in Health care
Latest SEC filings
What ENvue Medical, Inc. has filed recently, newest first. Each links to the original document on SEC EDGAR.
- August 31, 2026
- August 17, 2026Quarterly report 10-Q · period to June 30, 2026Revenue fell 52% to $239K versus the same quarter last year; diluted EPS -$1.98 versus -$1.03.
- August 14, 2026Late quarterly report notice NT 10-Q
- August 14, 2026
- August 12, 2026
- August 10, 2026
- July 24, 2026Proxy statement DEF 14A
- July 14, 2026Preliminary proxy statement PRE 14A
- July 14, 2026
- July 10, 2026
Insider trades
What the people running ENvue Medical, Inc. did with its shares, from the Form 4 filings they must send the SEC within two business days.
No insider trades were reported in the last 90 days.
| Date | Insider | What | Shares | Value |
|---|---|---|---|---|
| June 22, 2026 | Glibert Christian MichaelNo longer subject to section 1 | Sold | 210,000 | $144.5K |
Questions about FEED
What does ENvue Medical, Inc. do?
ENvue Medical, Inc. is registered with the SEC under industry code SIC 3842 (Orthopedic, Prosthetic & Surgical Appliances & Supplies). Its shares trade on NASDAQ under the ticker FEED.
Is ENvue Medical, Inc. profitable?
No. Over the twelve months to June 30, 2026 it reported a net loss of $21.1M on revenue of $1.9M.
How much revenue does ENvue Medical, Inc. make?
Over the twelve months to June 30, 2026 ENvue Medical, Inc. reported revenue of $1.9M. That is 17.7% less than a year earlier.
When did ENvue Medical, Inc. last report?
Its most recent periodic report is the quarterly report (10-Q) filed on August 17, 2026. It covers the period to June 30, 2026. Its newest filing of any kind is the bylaws or fiscal year changed from August 31, 2026.
Similar companies
Compare FEED with
Follow FEED
Get an email when ENvue Medical, Inc. files with the SEC: results, executive changes, material agreements and annual reports.
Follow FEED: get an email when it filesWhere the numbers come from
Financial figures are the values ENvue Medical, Inc. tagged in its own SEC filings (XBRL), taken from the latest filing for each period, so restatements replace older figures. Revenue, profit and cash flow are for full fiscal years unless marked as the last twelve months, which is the sum of the four most recent quarters. Where a company reports only the full year, the fourth quarter is the year minus the first three.
Prices are delayed end-of-day market data in the listing currency, and market cap moves with the price. P/E is shown only when earnings per share are positive. Nothing here is investment advice.